RecruitingNCT06909409
D Vitamin and Alveolar Macrophages in Idiopathic Pulmonal Fibrosis
Sponsor
University of Aarhus
Enrollment
120 participants
Start Date
Oct 11, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this observational study is to gain deeper insights into human macrophages and vitamin D, and their interplay, within Idiopathic Pulmonary Fibrosis (IPF). The overall questions, it aims to answer, are the following: Do IPF patients suffer from systemic and local (pulmonary) insufficient levels of vitamin D? Do IPF patients suffer from pro-fibrotic and pro-inflammatory pulmonary macrophages?
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- A clinical diagnosis of IPF, non-IPF ILD or lung cancer
- A signed informed consent
Exclusion Criteria1
- Do not speak Danish/Do not understand Danish
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06909409
Related Trials
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
NCT0695121752 locations
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
NCT069688459 locations
Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF
NCT070828421 location
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis
NCT073445588 locations
AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF
NCT071943823 locations